Defining and maintaining a high quality screening collection: the GSK experience
Understanding the quality of a screening collection is the first step to improving it and, as a result, the quality of the screening process. Understanding the quality of a screening collection is the first step to improving it and, as a result, the quality of the screening process. This article out...
Gespeichert in:
| Veröffentlicht in: | Drug discovery today 2006-03, Vol.11 (5-6), p.267-272 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 272 |
|---|---|
| container_issue | 5-6 |
| container_start_page | 267 |
| container_title | Drug discovery today |
| container_volume | 11 |
| creator | Lane, Stephen J. Eggleston, Drake S. Brinded, Keith A. Hollerton, John C. Taylor, Nicholas L. Readshaw, Simon A. |
| description | Understanding the quality of a screening collection is the first step to improving it and, as a result, the quality of the screening process.
Understanding the quality of a screening collection is the first step to improving it and, as a result, the quality of the screening process. This article outlines how this issue was approached at GlaxoSmithKline and some of the hurdles that needed to be overcome to achieve success. The article focuses specifically on the necessary software and hardware infrastructure needed, and at some of the extra benefits of such a project in terms of data mining and data modelling. |
| doi_str_mv | 10.1016/S1359-6446(05)03730-X |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67819512</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S135964460503730X</els_id><sourcerecordid>67819512</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-d4f0fcd161e2c33804e67784f7308683fb3f9ebc00587ce3144cdc2ece8834f03</originalsourceid><addsrcrecordid>eNqFkFFLwzAQx4MoOqcfQemLog_VpGnS1BeRqVMUFFTwLWTXyxbp2i3pRL-93Vbx0ack3O-fu_sRcsDoGaNMnr8wLvJYpqk8oeKU8ozT-H2D9JjKVCwUTzbb-y-yQ3ZD-KCUJbmQ22SHSaGopGmPPF-jdZWrxpGpimhqXNWY7h1N3HgSzRemdM13FMAjrgpQlyVC4-rqImomGA1fHiL8mqF3WAHukS1ryoD73dknb7c3r4O7-PFpeD-4eoyB57yJi9RSCwWTDBPgXNEUZZap1LZ7KKm4HXGb4wgoFSoD5CxNoYAEAZXibZb3yfH635mv5wsMjZ66AFiWpsJ6EbTMFMsFS1pQrEHwdQgerZ55NzX-WzOqlyr1SqVeetJU6JVK_d7mDrsGi9EUi79U564FjjrABDCl9aYCF_64TOR5opaTXq45bHV8OvQ6wEpV4XzrURe1-2eUH0pGkFg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67819512</pqid></control><display><type>article</type><title>Defining and maintaining a high quality screening collection: the GSK experience</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lane, Stephen J. ; Eggleston, Drake S. ; Brinded, Keith A. ; Hollerton, John C. ; Taylor, Nicholas L. ; Readshaw, Simon A.</creator><creatorcontrib>Lane, Stephen J. ; Eggleston, Drake S. ; Brinded, Keith A. ; Hollerton, John C. ; Taylor, Nicholas L. ; Readshaw, Simon A.</creatorcontrib><description>Understanding the quality of a screening collection is the first step to improving it and, as a result, the quality of the screening process.
Understanding the quality of a screening collection is the first step to improving it and, as a result, the quality of the screening process. This article outlines how this issue was approached at GlaxoSmithKline and some of the hurdles that needed to be overcome to achieve success. The article focuses specifically on the necessary software and hardware infrastructure needed, and at some of the extra benefits of such a project in terms of data mining and data modelling.</description><identifier>ISSN: 1359-6446</identifier><identifier>EISSN: 1878-5832</identifier><identifier>DOI: 10.1016/S1359-6446(05)03730-X</identifier><identifier>PMID: 16580604</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>array ; Biological and medical sciences ; Chromatography, High Pressure Liquid ; Combinatorial Chemistry Techniques - methods ; Combinatorial Chemistry Techniques - organization & administration ; Computers ; data mining ; Drug Industry - methods ; General pharmacology ; GlaxoSmithKline ; HTS ; Information Storage and Retrieval - methods ; Magnetic Resonance Spectroscopy ; Mass Spectrometry ; Medical sciences ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; platelookup ; Quality Control ; Software</subject><ispartof>Drug discovery today, 2006-03, Vol.11 (5-6), p.267-272</ispartof><rights>2006 Elsevier Ltd</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-d4f0fcd161e2c33804e67784f7308683fb3f9ebc00587ce3144cdc2ece8834f03</citedby><cites>FETCH-LOGICAL-c393t-d4f0fcd161e2c33804e67784f7308683fb3f9ebc00587ce3144cdc2ece8834f03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S135964460503730X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17599280$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16580604$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lane, Stephen J.</creatorcontrib><creatorcontrib>Eggleston, Drake S.</creatorcontrib><creatorcontrib>Brinded, Keith A.</creatorcontrib><creatorcontrib>Hollerton, John C.</creatorcontrib><creatorcontrib>Taylor, Nicholas L.</creatorcontrib><creatorcontrib>Readshaw, Simon A.</creatorcontrib><title>Defining and maintaining a high quality screening collection: the GSK experience</title><title>Drug discovery today</title><addtitle>Drug Discov Today</addtitle><description>Understanding the quality of a screening collection is the first step to improving it and, as a result, the quality of the screening process.
Understanding the quality of a screening collection is the first step to improving it and, as a result, the quality of the screening process. This article outlines how this issue was approached at GlaxoSmithKline and some of the hurdles that needed to be overcome to achieve success. The article focuses specifically on the necessary software and hardware infrastructure needed, and at some of the extra benefits of such a project in terms of data mining and data modelling.</description><subject>array</subject><subject>Biological and medical sciences</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Combinatorial Chemistry Techniques - methods</subject><subject>Combinatorial Chemistry Techniques - organization & administration</subject><subject>Computers</subject><subject>data mining</subject><subject>Drug Industry - methods</subject><subject>General pharmacology</subject><subject>GlaxoSmithKline</subject><subject>HTS</subject><subject>Information Storage and Retrieval - methods</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Mass Spectrometry</subject><subject>Medical sciences</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>platelookup</subject><subject>Quality Control</subject><subject>Software</subject><issn>1359-6446</issn><issn>1878-5832</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkFFLwzAQx4MoOqcfQemLog_VpGnS1BeRqVMUFFTwLWTXyxbp2i3pRL-93Vbx0ack3O-fu_sRcsDoGaNMnr8wLvJYpqk8oeKU8ozT-H2D9JjKVCwUTzbb-y-yQ3ZD-KCUJbmQ22SHSaGopGmPPF-jdZWrxpGpimhqXNWY7h1N3HgSzRemdM13FMAjrgpQlyVC4-rqImomGA1fHiL8mqF3WAHukS1ryoD73dknb7c3r4O7-PFpeD-4eoyB57yJi9RSCwWTDBPgXNEUZZap1LZ7KKm4HXGb4wgoFSoD5CxNoYAEAZXibZb3yfH635mv5wsMjZ66AFiWpsJ6EbTMFMsFS1pQrEHwdQgerZ55NzX-WzOqlyr1SqVeetJU6JVK_d7mDrsGi9EUi79U564FjjrABDCl9aYCF_64TOR5opaTXq45bHV8OvQ6wEpV4XzrURe1-2eUH0pGkFg</recordid><startdate>20060301</startdate><enddate>20060301</enddate><creator>Lane, Stephen J.</creator><creator>Eggleston, Drake S.</creator><creator>Brinded, Keith A.</creator><creator>Hollerton, John C.</creator><creator>Taylor, Nicholas L.</creator><creator>Readshaw, Simon A.</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060301</creationdate><title>Defining and maintaining a high quality screening collection: the GSK experience</title><author>Lane, Stephen J. ; Eggleston, Drake S. ; Brinded, Keith A. ; Hollerton, John C. ; Taylor, Nicholas L. ; Readshaw, Simon A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-d4f0fcd161e2c33804e67784f7308683fb3f9ebc00587ce3144cdc2ece8834f03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>array</topic><topic>Biological and medical sciences</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Combinatorial Chemistry Techniques - methods</topic><topic>Combinatorial Chemistry Techniques - organization & administration</topic><topic>Computers</topic><topic>data mining</topic><topic>Drug Industry - methods</topic><topic>General pharmacology</topic><topic>GlaxoSmithKline</topic><topic>HTS</topic><topic>Information Storage and Retrieval - methods</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Mass Spectrometry</topic><topic>Medical sciences</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>platelookup</topic><topic>Quality Control</topic><topic>Software</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lane, Stephen J.</creatorcontrib><creatorcontrib>Eggleston, Drake S.</creatorcontrib><creatorcontrib>Brinded, Keith A.</creatorcontrib><creatorcontrib>Hollerton, John C.</creatorcontrib><creatorcontrib>Taylor, Nicholas L.</creatorcontrib><creatorcontrib>Readshaw, Simon A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Drug discovery today</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lane, Stephen J.</au><au>Eggleston, Drake S.</au><au>Brinded, Keith A.</au><au>Hollerton, John C.</au><au>Taylor, Nicholas L.</au><au>Readshaw, Simon A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Defining and maintaining a high quality screening collection: the GSK experience</atitle><jtitle>Drug discovery today</jtitle><addtitle>Drug Discov Today</addtitle><date>2006-03-01</date><risdate>2006</risdate><volume>11</volume><issue>5-6</issue><spage>267</spage><epage>272</epage><pages>267-272</pages><issn>1359-6446</issn><eissn>1878-5832</eissn><abstract>Understanding the quality of a screening collection is the first step to improving it and, as a result, the quality of the screening process.
Understanding the quality of a screening collection is the first step to improving it and, as a result, the quality of the screening process. This article outlines how this issue was approached at GlaxoSmithKline and some of the hurdles that needed to be overcome to achieve success. The article focuses specifically on the necessary software and hardware infrastructure needed, and at some of the extra benefits of such a project in terms of data mining and data modelling.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>16580604</pmid><doi>10.1016/S1359-6446(05)03730-X</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1359-6446 |
| ispartof | Drug discovery today, 2006-03, Vol.11 (5-6), p.267-272 |
| issn | 1359-6446 1878-5832 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67819512 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | array Biological and medical sciences Chromatography, High Pressure Liquid Combinatorial Chemistry Techniques - methods Combinatorial Chemistry Techniques - organization & administration Computers data mining Drug Industry - methods General pharmacology GlaxoSmithKline HTS Information Storage and Retrieval - methods Magnetic Resonance Spectroscopy Mass Spectrometry Medical sciences Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments platelookup Quality Control Software |
| title | Defining and maintaining a high quality screening collection: the GSK experience |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T22%3A49%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Defining%20and%20maintaining%20a%20high%20quality%20screening%20collection:%20the%20GSK%20experience&rft.jtitle=Drug%20discovery%20today&rft.au=Lane,%20Stephen%20J.&rft.date=2006-03-01&rft.volume=11&rft.issue=5-6&rft.spage=267&rft.epage=272&rft.pages=267-272&rft.issn=1359-6446&rft.eissn=1878-5832&rft_id=info:doi/10.1016/S1359-6446(05)03730-X&rft_dat=%3Cproquest_cross%3E67819512%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67819512&rft_id=info:pmid/16580604&rft_els_id=S135964460503730X&rfr_iscdi=true |